Morphosys.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
100% 
Page quality
55% 
Page structure
75% 
Link structure
80% 
Server
45% 
External factors
100% 
SEO Score
Response time
0.13 s
File size
51.30 kB
Words
548
Media files
17
Number of links
59 internal / 2 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
MorphoSys | A global biopharmaceutical company
The length of the page title is perfect. (446 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Learn about MorphoSys. A commercial-stage biopharmaceutical company that develops innovative medicines, aspiring to redefine how cancer is treated.
The length of the meta description is perfect. (941 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.morphosys.com/de/home
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: de
Language defined in HTML: de
Server location: United States of America
The following language is defined by HTML: de
Alternate/Hreflang Links
(Somewhat important)
The specified alternate links have no errors.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
descriptionLearn about MorphoSys. A commercial-stage biopharmaceutical company that develops innovative medicines, aspiring to redefine how cancer is treated.
GeneratorDrupal 10 (https://www.drupal.org)
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1, shrink-to-fit=no
langde
x-ua-compatibleie=edge
charsetutf-8

Test up to 1.000 webpages of morphosys.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Some words from the page title are not used within the pages content
Words from the H1 heading are not used in the page content.
There are 4 text duplicates on this page:
  • Duplicate 1: Are you a U.S. resident? This portion of the MorphoSys website is inte...
  • Duplicate 2: Are you a U.S. resident? This portion of the MorphoSys website is inte...
The average number of words per sentence of 7.49 words is low.
This page contains 548 words. That's ok.
37.8% of the text are stop words.
The page contains a listing, which indicates a good text layout.
9 paragraphs were found on this page.
No placeholders texts or images were found.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
A viewport "width=device-width, initial-scale=1, shrink-to-fit=no" is provided.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 11 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
/themes/morphosys/logo.svgHome
.../2023-03/home_stage_v2.jpg?itok=VTtkTGGbTwo women laugh together outsideTwo women laugh together outside
...3-03/home_stage_mobile.jpg?itok=jJGKjP6YTwo women laugh together outsideTwo women laugh together outside
.../2023-03/home_pipeline.jpg?itok=CSxne-u5Woman in a lab looks into a microscope
...3/home_pipeline_mobile.jpg?itok=zGANagG9Woman in a lab looks into a microscope
...cial-media-icons/icon_icon_linked-01.svgLinked In
...s/social-media-icons/icon_twitter-01.svgTwitter
...cial-media-icons/icon_icon_linked-01.svgLinked In
...s/social-media-icons/icon_twitter-01.svgTwitter
...cial-media-icons/icon_icon_linked-01.svgLinked In
...s/social-media-icons/icon_twitter-01.svgTwitter
...ve Workspace MorphoSys.png?itok=4kgNKocEMorphoSys colleagues during a Leadership Training
...space Mobile MorphoSys.png?itok=bpbslS1TMorphoSys colleagues during a Leadership Training
...10/Website Icon People.png?itok=jw8T6qbYIcon of three people
...-10/Website Icon Woman.png?itok=WHDuSjYHIcon of a woman
...-10/Website Icon Earth.png?itok=GphhJcrVicon of the world
...10/Website Icon Winner.png?itok=9A4ZF5xtIcon of a winner

Page structure

H1 heading
(Critically important)
Mehr Leben für Menschen mit Krebs
The H1 heading is perfect.
Headings
(Important)
The structure of headings is missing one or more levels. Do not skip heading levels.
There are 27 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H1 Mehr Leben für Menschen mit Krebs
H2 Flyout
H2 Unsere Forschung
H2 Neuartige Therapien entwickeln
H2 Aktuelle Mitteilungen
H2 Unser Team
H2 Ein inklusives Arbeitsumfeld fördern
H2 IN ZAHLEN
H2 Aktuelle Veranstaltungen
H2 Veröffentlichung des Halbjahresberichts 2024
H2 Veröffentlichung der 3. Quartalsmitteilung 2024
H2 Footer-first-column
H2 Footer-second-column
H2 Footer-third-column
H2 Footer-fifth-column
H3 Forschung
H3 Über uns
H3 Karriere
H3 Investoren
H3 Medien
H3 MorphoSys und Novartis unterzeichnen Vereinbarung zur Beendigung der Börsennotierung und beabsichtigen Durchführung eines verschmelzungsrechtlichen Squeeze-Outs der Minderheitsaktionäre der MorphoSys
H3 Ad hoc: Novartis BidCo Germany AG beabsichtigt Durchführung eines verschmelzungsrechtlichen Squeeze-outs der Minderheitsaktionäre der MorphoSys AG
H3 Ad hoc: Arkadius Pichota und Lukas Gilgen unter Ersetzung des bisherigen CEO und CFO zum Vorstand der MorphoSys AG ernannt
H5 464
H5 60 %
H5 37
H5 41 %
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 2 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.morphosys.com/de/homeAnchor Skip to main content
https://www.morphosys.com/en/homeen
https://www.morphosys.com/de/homede
/de/investoren/Novartis-Takeov...Subdomain Übernahme von MorphoSys durch Novartis abgeschlossen. MorphoSys ist nun ein Novartis-Unternehmen.
https://www.morphosys.com/deIMG-ALT Home
A-TITLE Home
/de/unsere-wissenschaftForschung
/de/unsere-wissenschaftMehr erfahren
/de/unsere-pipelinePipeline
/de/unsere-pipeline/pelabresibPelabresib
/de/unsere-pipeline/tulmimetostatTulmimetostat
/de/ueber-unsÜber uns
/de/ueber-unsText duplicate Mehr erfahren
/de/managementManagement
/de/ueber-uns/verantwortungVerantwortung
/de/ueber-uns/unsere-geschichteGeschichte
/de/karriereKarriere
/de/karriereText duplicate Mehr erfahren
/de/careers/job-openingsStellenangebote
/de/investorenInvestoren
/de/investorenText duplicate Mehr erfahren
/de/investoren/Novartis-Takeov...Novartis Übernahmeangebot
/de/investoren/finanzinformati...Finanzinformationen
/de/investoren/corporate-gover...Corporate Governance
/de/investoren/aktieninformati...Informationen zur Aktie
https://www.morphosys.com/de/hvJahreshauptversammlung 2023
/de/hauptversammlungen-archivArchiv Hauptversammlungen
/de/veranstaltungen-und-konfer...Alle Veranstaltungen
/de/medienMedien
/de/medienText duplicate Mehr erfahren
/de/news/allPressemitteilungen
https://www.morphosys.com/en/homeText duplicate en
https://www.morphosys.com/de/homeText duplicate de
/de/ueber-unsText duplicate Mehr erfahren
/de/unsere-pipelineText duplicate Mehr erfahren
/de/news/morphosys-und-novarti...MorphoSys und Novartis unterzeichnen Vereinbarung zur Beendigung der Börsennotierung und beabsichtigen Durchführung eines verschmelzungsrechtlichen Squeeze-O...
/de/news/morphosys-und-novarti...Zur Mitteilung
/de/news/ad-hoc-novartis-bidco...Ad hoc: Novartis BidCo Germany AG beabsichtigt Durchführung eines verschmelzungsrechtlichen Squeeze-outs der Minderheitsaktionäre der MorphoSys AG
/de/news/ad-hoc-novartis-bidco...Text duplicate Zur Mitteilung
/de/news/ad-hoc-arkadius-picho...Ad hoc: Arkadius Pichota und Lukas Gilgen unter Ersetzung des bisherigen CEO und CFO zum Vorstand der MorphoSys AG ernannt
/de/news/ad-hoc-arkadius-picho...Text duplicate Zur Mitteilung
/de/news/allAlle ansehen
/de/careers/job-openingsWerde Teil unseres Teams
/de/ics/24894Subdomain Kalendereintrag speichern
/de/ics/24897Subdomain Text duplicate Kalendereintrag speichern
/de/veranstaltungen-und-konfer...Text duplicate Alle Veranstaltungen
/de/karriereText duplicate Karriere
/de/managementText duplicate Management
/de/unsere-pipelineText duplicate Pipeline
/de/ueber-uns/verantwortungText duplicate Verantwortung
/de/investorenText duplicate Investoren
/de/medienText duplicate Medien
https://www.linkedin.com/compa...New window External Subdomain No Text
https://twitter.com/morphosysNew window External No Text
/de/impressumImpressum
/de/nutzungsbedingungenNutzungsbedingungen
/de/datenschutzDatenschutz
/de/kontaktKontakt
https://www.morphosys.com/deSubdomain Abbrechen
https://www.morphosys.com/deSubdomain Nein
https://www.morphosys.com/deSubdomain Text duplicate Nein
https://www.morphosys.com/deSubdomain Text duplicate Nein

Server configuration

HTTP redirects
(Critically important)
The checked page does not redirect to another URL.
HTTP header
(Important)
The HTML page should be transferred using GZip compression.
No X-Powered HTTP header is sent.
Performance
(Somewhat important)
The page response time is excellent with 0.13 seconds.
The file size of the HTML document is fine (51 kB).

HTTP Response Header

NameValue
dateThu, 27 Jun 2024 23:47:09 GMT
content-typetext/html; charset=UTF-8
content-length52558
x-content-type-optionsnosniff
cache-controlmax-age=900, public
content-languagede
x-frame-optionsSAMEORIGIN
expiresSun, 19 Nov 1978 05:00:00 GMT
last-modifiedThu, 27 Jun 2024 13:14:27 GMT
etag"1719494067"
varyCookie
access-control-allow-origin*
strict-transport-securitymax-age=15724800
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 195 referring domains.
This page has 6,992 backlinks.
This page has backlinks from 151 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 0 shares and comments on Facebook.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.md
Disallow: /composer/Metapackage/README.txt
Disallow: /composer/Plugin/ProjectMessage/README.md
Disallow: /composer/Plugin/Scaffold/README.md
Disallow: /composer/Plugin/VendorHardening/README.txt
Disallow: /composer/Template/README.txt
Disallow: /modules/README.txt
Disallow: /sites/README.txt
Disallow: /themes/README.txt
Disallow: /web.config
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register
Disallow: /user/password
Disallow: /user/login
Disallow: /user/logout
Disallow: /media/oembed
Disallow: /*/media/oembed
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password
Disallow: /index.php/user/register
Disallow: /index.php/user/login
Disallow: /index.php/user/logout
Disallow: /index.php/media/oembed
Disallow: /index.php/*/media/oembed

Similar sites

Search preview

www.morphosys.com › home
MorphoSys | A global biopharmaceutical company
Learn about MorphoSys. A commercial-stage biopharmaceutical company that develops innovative medicines, aspiring to redefine how cancer is treated.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
MorphoSys75%Check
MorphoSys AG67%Check
Krebs50%Check
Leben50%Check
Menschen50%Check
Novartis43%Check
Forschung43%Check
Aktuelle43%Check
Durchführung43%Check
verschmelzungsrechtlichen43%Check
Show more keywords and terms

Test up to 1.000 webpages of morphosys.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions